Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment

BACKGROUND: Macrolide is the drug of choice to treat human campylobacteriosis, but Campylobacter resistance to this antibiotic is rising. The mechanisms employed by Campylobacter jejuni to adapt to erythromycin treatment remain unknown and are examined in this study. The transcriptomic response of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Qingqing, Muraoka, Wayne T, Shen, Zhangqi, Sahin, Orhan, Wang, Hongning, Wu, Zuowei, Liu, Peng, Zhang, Qijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694039/
https://www.ncbi.nlm.nih.gov/pubmed/23767761
http://dx.doi.org/10.1186/1471-2180-13-133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694039/
https://www.ncbi.nlm.nih.gov/pubmed/23767761
http://dx.doi.org/10.1186/1471-2180-13-133

Ejemplares similares